Si/sub 3/N/sub 4/:B
Decreased bacteria activity on Si<sub>3</sub>N<sub>4</sub> surfaces compared with PEEK or titanium
... (Si 3 N 4 ) – were tested to understand their respective susceptibility to bacterial infection with Staphylococcus epidermidis, Staphlococcus aureus, Pseudomonas aeruginosa, Escherichia coli ...
12
NH<sub>4</sub>HCO<sub>3</sub> gas-generating liposomal nanoparticle for photoacoustic imaging in breast cancer
... NH 4 HCO 3 solutions with regard to time ...NH 4 HCO 3 solution quickly reached a peak value and decreased soon ...NH 4 HCO 3 ...NH 4 HCO 3 decomposes into CO 2 , ...
11
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... culture dishes; cells were either untreated (control), or treated with DTX (1 nM) or MgNPs-Fe 3 O 4 (10 µ g/mL or 100 µ g/mL) in the absence or presence of DTX (1 nM). Aspirated medium was collected to ...
10
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... Bis/Dex/Fe 3 O 4 and subjected to RF exposure. When Fe 3 O 4 was cultured with OBs and OCs under RF exposure, the cell survival rate declined to ~ ...Fe 3 O 4 will overheat the ...
12
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... Fe 3 O 4 -magnetic nanoparticles (MNPs-Fe 3 O 4 ) on the expression of KCNQ 1 in cardiac muscle of mice at rest and at different times following a single bout of swimming ...MNPs-Fe 3 O ...
8
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... Fe 3 O 4 ...Fe 3 O 4 ...Fe 3 O 4 - ...Fe 3 O 4 - MNP to be a more effective treatment, but also improved the efficiency of Fe 3 O 4 -MNP-DNR-5-BrTet ...
9
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... molecular weights. Immunoblots for expression of p38, p-p38, JNK, p-JNK, HO-1, ERK, c-Jun, cleaved caspase 3, Bcl2, Bax, P50, p53, Nrf2, Akt, and GAPDH were detected. All antibodies for Western blot in this study ...
15
Daunorubicin-loaded magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> overcome multidrug resistance and induce apoptosis of K562-n/VCR cells <em>in vivo</em>
... Fe 3 O 4 (MNPs-Fe 3 O 4 ) on K562-n/VCR cells in ...group B received DNR, group C received MNPs-Fe 3 O 4 , and group D received DNR-loaded MNPs-Fe 3 O ...
8
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... Nanotechnology offers an efficient alternative for cancer diagnostics and tumor target treatment due to the unique properties of nanostructures, such as large surface-to-volume ratio, porous structure, embedded effect, ...
7
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... Fe 3 O 4 magnetic nanoparticles (Fe 3 O 4 ...Fe 3 O 4 -MNPs were synthesized, and their characteristics such as particle size, zeta potential, and X-ray diffraction patterns were ...
6
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... HAuCl 4 solution containing ...in 3% bovine serum albumin and phosphate-buffered solution at 37 ° C for one hour to block excess active groups and nonspecific binding sites on the ...
11
Synergistic effect of a combination of nanoparticulate Fe<sub>3</sub>O<sub>4</sub> and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells
... Fe 3 O 4 had a normal healthy shape, as demonstrated by their clear cytoskeletons (Figure 3A and ...Fe 3 O 4 with or without ...Fe 3 O 4 magnetic nanoparticle group stained ...
10
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... κ B, survivin, and β -actin were purchased from Santa Cruz Biotechnology (Santa Cruz, ...MNPs-Fe 3 O 4 (State Key Lab of Bioelectronics, Nanjing, China) were well distributed in RPMI 1640 medium ...
9
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... κ B might help circumvent resistance to conventional ...κ B protein. Interestingly, in the present study, MNP-Fe 3 O 4 combined with adriamycin or daunorubicin increased upregulation of p53 ...
6
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... Fe 3 O 4 -PLGA-PEG 2000 -doxorubicin has dose-dependent and time-dependent cytotoxicity against the A549 lung can- cer cell line (IC 50 ...Fe 3 O 4 -PLGA-PEG 3000 -doxorubicin has dose- ...
16
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... The procedures for generation and drug loading of TfDMP are shown in Figure 1. By coupling GA with amino- immobilized Fe 3 O 4 @SiO 2 , the surface of the magnetic nanoparticle can be modified with both ...
9
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... and the blots were stained with specific primary antibodies, including anti-bcl-2, anti-bax, anti-survivin, anti-bcl-rambo, anti-active caspase-3, and anti-GAPDH antibodies overnight at 4 ° C. Then, the ...
8
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Nanomaterials interact directly with tissues and cells after entering the body. Therefore, the most basic criteria for its clinical application are safety and good biocompatibility, which is also important to the ...
6
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... Fe 3 O 4 NPs on I MEP with a half-maximal inhibitory concentration (IC 50 ) value of 46 µ M could derive from the direct binding of the nanoparticles to the pores of the MEP-induced chan- ...Fe 3 O ...
10
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... day 3 after ...day 3, and thereafter decreased ...Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...day 3 after dosing, indicating that the liver and spleen were ...
6